MENLO PARK, CA, Recode announced it has secured $15 million in funding, led by The Cystic Fibrosis Foundation.
Recode announced it has secured $15 million in funding, led by The Cystic Fibrosis Foundation. This investment is intended to be used to develop a gene editing therapy that could be delivered into the lung cells of people with cystic fibrosis.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
